The PE Ratio as of September 2024 (TTM) for NLS Pharmaceutics AG (NLSP) is -0.41

According to NLS Pharmaceutics AG’s latest financial reports and current stock price. The company's current PE Ratio is -0.41. This represents a change of -56.77% compared to the average of -0.95 of the last 4 quarters.

NLS Pharmaceutics AG (NLSP) Historical PE Ratio (quarterly & annually)

How has NLSP PE Ratio performed in the past?

The mean historical PE Ratio of NLS Pharmaceutics AG over the last ten years is -3.90. The current -0.41 PE Ratio has changed 952.58% with respect to the historical average. Over the past ten years (40 quarters), NLSP's PE Ratio was at its highest in in the June 2022 quarter at -0.27. The PE Ratio was at its lowest in in the June 2020 quarter at -6.53.

NLS Pharmaceutics AG (NLSP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NLS Pharmaceutics AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NLS Pharmaceutics AG (NLSP) Average PE Ratio

How has NLSP PE Ratio performed in the past?

The current PE Ratio of NLS Pharmaceutics AG (NLSP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NLS Pharmaceutics AG (NLSP) PE Ratio vs. Peers

How is NLSP’s PE Ratio compared to its peers?

NLS Pharmaceutics AG’s PE Ratio is greater than NeuroBo Pharmaceuticals, Inc. (-0.73), greater than Indaptus Therapeutics, Inc. (-0.78), less than Pasithea Therapeutics Corp. (-0.27), greater than Quoin Pharmaceuticals, Ltd. (-0.47), greater than Lixte Biotechnology Holdings, Inc. (-1.09), greater than Anebulo Pharmaceuticals, Inc. (-4.99), greater than NervGen Pharma Corp. (-7.99), greater than Acrivon Therapeutics, Inc. Common Stock (-4.23), greater than Protagenic Therapeutics, Inc. (-0.52), greater than Miromatrix Medical Inc. (-3.41), greater than Rezolute, Inc. (-3.80), greater than HCW Biologics Inc. (-0.69), greater than Eliem Therapeutics, Inc. (-3.49), greater than Molecular Partners AG (-2.67), greater than Assembly Biosciences, Inc. (-2.10), greater than Neoleukin Therapeutics, Inc. (-0.98), greater than Instil Bio, Inc. (-0.78), less than CytomX Therapeutics, Inc. (9.19), greater than Achilles Therapeutics plc (-0.45),

Build a custom stock screener for NLS Pharmaceutics AG (NLSP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NLS Pharmaceutics AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NLS Pharmaceutics AG (NLSP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NLS Pharmaceutics AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.